CUPRIMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cuprimine, and when can generic versions of Cuprimine launch?
Cuprimine is a drug marketed by Valeant Pharms Intl and is included in one NDA.
The generic ingredient in CUPRIMINE is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cuprimine
A generic version of CUPRIMINE was approved as penicillamine by ANI PHARMS on May 7th, 2019.
Summary for CUPRIMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,575 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CUPRIMINE |
| What excipients (inactive ingredients) are in CUPRIMINE? | CUPRIMINE excipients list |
| DailyMed Link: | CUPRIMINE at DailyMed |
Recent Clinical Trials for CUPRIMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. |
Pharmacology for CUPRIMINE
| Drug Class | Antirheumatic Agent |
Anatomical Therapeutic Chemical (ATC) Classes for CUPRIMINE
US Patents and Regulatory Information for CUPRIMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
